1068PThe observational ENCORE study: Cetuximab + platinum-based therapy (PBT) for first-line (1L) treatment of patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
Le Tourneau, C., Ghiani, M., Cau, M.C., Depenni, R., Ronzino, G., Livi, L., Montesarchio, V., Bretagne, M., Saint-Ghislain, M., Schulten, J., Messinger, D., Sbrana, A., Ghi, M.G.Volume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx374.024
Date:
September, 2017
File:
PDF, 95 KB
2017